APA

Berger T., Jacobi C., Haas J., Ransmayr G., Guger M., Zettl U. K., Di Pauli F., Taumberger B., Wietek S., Meuer S., Reindl M. & Giese T. (20150217). Predicting therapeutic efficacy of intravenous immunoglobulin (IVIG) in individual patients with relapsing remitting multiple sclerosis (RRMS) by functional genomics. : Journal of neuroimmunology.

Chicago

Berger Thomas, Jacobi Christian, Haas Judith, Ransmayr Gerhard, Guger Michael, Zettl Uwe K, Di Pauli Franziska, Taumberger Birgit, Wietek Stefan, Meuer Stefan, Reindl Markus and Giese Thomas. 20150217. Predicting therapeutic efficacy of intravenous immunoglobulin (IVIG) in individual patients with relapsing remitting multiple sclerosis (RRMS) by functional genomics. : Journal of neuroimmunology.

Harvard

Berger T., Jacobi C., Haas J., Ransmayr G., Guger M., Zettl U. K., Di Pauli F., Taumberger B., Wietek S., Meuer S., Reindl M. and Giese T. (20150217). Predicting therapeutic efficacy of intravenous immunoglobulin (IVIG) in individual patients with relapsing remitting multiple sclerosis (RRMS) by functional genomics. : Journal of neuroimmunology.

MLA

Berger Thomas, Jacobi Christian, Haas Judith, Ransmayr Gerhard, Guger Michael, Zettl Uwe K, Di Pauli Franziska, Taumberger Birgit, Wietek Stefan, Meuer Stefan, Reindl Markus and Giese Thomas. Predicting therapeutic efficacy of intravenous immunoglobulin (IVIG) in individual patients with relapsing remitting multiple sclerosis (RRMS) by functional genomics. : Journal of neuroimmunology. 20150217.